OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Perioperative treatment with the new synthetic TLR‐4 agonist GLA‐SE reduces cancer metastasis without adverse effects
Pini Matzner, Liat Sorski, Lee Shaashua, et al.
International Journal of Cancer (2015) Vol. 138, Iss. 7, pp. 1754-1764
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Toll‐like receptors: the swiss army knife of immunity and vaccine development
Jennifer K. Dowling, Ashley Mansell
Clinical & Translational Immunology (2016) Vol. 5, Iss. 5
Open Access | Times Cited: 250

Surgical stress and cancer progression: the twisted tango
Zhiwei Chen, Peidong Zhang, Ya Xu, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 168

Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity
Orneala Bakos, Christine Lawson, Samuel G. Rouleau, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 157

Perioperative Anesthesia Care and Tumor Progression
Mir Wais Sekandarzad, André van Zundert, Philipp Lirk, et al.
Anesthesia & Analgesia (2016) Vol. 124, Iss. 5, pp. 1697-1708
Closed Access | Times Cited: 147

TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings
Maryam A. Shetab Boushehri, Alf Lamprecht
Molecular Pharmaceutics (2018) Vol. 15, Iss. 11, pp. 4777-4800
Closed Access | Times Cited: 135

Merkel cell carcinoma: An update and review
Tiffany Tello, Kathleen Coggshall, Sue S. Yom, et al.
Journal of the American Academy of Dermatology (2017) Vol. 78, Iss. 3, pp. 445-454
Closed Access | Times Cited: 103

Implicating anaesthesia and the perioperative period in cancer recurrence and metastasis
Julia Dubowitz, Erica K. Sloan, Bernhard Riedel
Clinical & Experimental Metastasis (2017) Vol. 35, Iss. 4, pp. 347-358
Closed Access | Times Cited: 93

Harnessing cancer immunotherapy during the unexploited immediate perioperative period
Pini Matzner, Elad Sandbank, Elad Neeman, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 5, pp. 313-326
Closed Access | Times Cited: 83

Trial Watch: Immunotherapy plus radiation therapy for oncological indications
Erika Vacchelli, Norma Bloy, Fernando Aranda, et al.
OncoImmunology (2016) Vol. 5, Iss. 9, pp. e1214790-e1214790
Open Access | Times Cited: 73

Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies
Alessia Villani, Gabriella Fabbrocini, Cláudia Costa, et al.
Dermatology and Therapy (2019) Vol. 9, Iss. 2, pp. 209-222
Open Access | Times Cited: 69

Surgical Stress Promotes Tumor Progression: A Focus on the Impact of the Immune Response
Amblessed Onuma, Hongji Zhang, Lindsay A. Gil, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 4096-4096
Open Access | Times Cited: 53

The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
Lingling Huang, Xiaoyan Ge, Yang Liu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1228-1228
Open Access | Times Cited: 34

Therapeutic Targeting of TLR4 for Inflammation, Infection, and Cancer: A Perspective for Disaccharide Lipid A Mimetics
Holger Heine, Alla Zamyatina
Pharmaceuticals (2022) Vol. 16, Iss. 1, pp. 23-23
Open Access | Times Cited: 34

Activation of μ-opioid receptor and Toll-like receptor 4 by plasma from morphine-treated mice
Nan Xie, Fábio Pereira Gomes, Vandana Deora, et al.
Brain Behavior and Immunity (2016) Vol. 61, pp. 244-258
Closed Access | Times Cited: 47

TLR Agonists as Adjuvants for Cancer Vaccines
Jikun Li, Jesse J. Balic, Liang Yu, et al.
Advances in experimental medicine and biology (2017), pp. 195-212
Open Access | Times Cited: 44

TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme—Future Perspectives
Jakub Litak, Cezary Grochowski, Joanna Litak, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3114-3114
Open Access | Times Cited: 35

Interaction of Opioids with TLR4—Mechanisms and Ramifications
Mai Mahmoud Gabr, Iqira Saeed, Jared A. Miles, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5274-5274
Open Access | Times Cited: 30

EZH2 Inhibitor Enhances the STING Agonist‒Induced Antitumor Immunity in Melanoma
Tianxiao Xu, Jie Dai, Lirui Tang, et al.
Journal of Investigative Dermatology (2021) Vol. 142, Iss. 4, pp. 1158-1170.e8
Open Access | Times Cited: 26

AN OVERVIEW OF RECOMBINANT VACCINE TECHNOLOGY, ADJUVANTS AND VACCINE DELIVERY METHODS
Shuaibu Abdullahi Hudu, Saadatu Haruna Shinkafi, Shuaibu Umar
International Journal of Pharmacy and Pharmaceutical Sciences (2016) Vol. 8, Iss. 11, pp. 19-19
Open Access | Times Cited: 28

A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides
Maryam A. Shetab Boushehri, Mona M.A. Abdel-Mottaleb, Arnaud Béduneau, et al.
Drug Delivery (2018) Vol. 25, Iss. 1, pp. 1414-1425
Open Access | Times Cited: 28

Metastasis Prevention: Focus on Metastatic Circulating Tumor Cells
Maxim E. Menyailo, Ustinia A. Bokova, Elena E. Ivanyuk, et al.
Molecular Diagnosis & Therapy (2021) Vol. 25, Iss. 5, pp. 549-562
Closed Access | Times Cited: 22

Lipid metabolism in tumor immunology and immunotherapy
Lisa K. Duong, Halil Ibrahim Corbali, Thomas S. Riad, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 9

Effect of Perioperative Opioids on Cancer-Relevant Circulating Parameters: Mu Opioid Receptor and Toll-Like Receptor 4 Activation Potential, and Proteolytic Profile
Nan Xie, Nicholas Matigian, Tharindu Vithanage, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 10, pp. 2319-2327
Open Access | Times Cited: 23

Page 1 - Next Page

Scroll to top